Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UAB Medicine
Birmingham Alabama 35294

A randomized, double blind study of esketamine nasal spray plus an oral antidepressant to prevent return of depression symptoms in patients with treatment-resistant depression (SUSTAIN-1)

University of Alabama at Birmingham
Birmingham Alabama 35294

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

MMG
Dothan Alabama 36303

Does Your Child Have Depression?

View More ▼

Birmingham Alabama 35213

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Birmingham Alabama

A clinical trial seeking patients for a research study for the treatment of Depressive Disorder, Major

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Major Depressive Disorder (MDD)

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Intranasal Esketamine for the treatment of Depressive Disorder, Treatment-Resistant

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Esketamine and Placebo to evaluate Depressive Disorder, Major

Dothan Alabama 36303

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Dothan Alabama 36303

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Dothan Alabama

A clinical trial seeking patients for a research study for the treatment of Depressive Disorder, Major

Dothan Alabama 36303

A clinical trial to evaluate treatments using cariprazine and placebo for patients with Bipolar Disorder or Depression

UPDATED

Dothan Alabama 36303

Patients are needed to participate in a clinical research study of Rapastinel and Placebo to evaluate Depressive Disorder, Major

UPDATED

Dothan Alabama 36303

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

Arizona

MMG
Tucson Arizona 85724

Does Your Child Have Depression?

View More ▼

Phoenix Arizona 85016

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

UPDATED

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study of Rapastinel and Placebo to evaluate Depressive Disorder, Major

UPDATED

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

Tucson Arizona 85724

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

Tucson Arizona 85712

Patients are needed to participate in a clinical research study of Vortioxetine and Placebo to evaluate Major Depressive Disorder

Arkansas

MMG
Georgetown Arkansas 72143

Does Your Child Have Depression?

Research Center
Little Rock Arkansas

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects with Severe Postpartum Depression and Adult Female Subjects with Moderate Postpartum Depression

Research Center
Little Rock Arkansas

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects with Severe Postpartum Depression and Adult Female Subjects with Moderate Postpartum Depression

Preferred Research Partners
Little Rock Arkansas 72211

A randomized, double blind study of esketamine nasal spray plus an oral antidepressant to prevent return of depression symptoms in patients with treatment-resistant depression (SUSTAIN-1)

Preferred Research Partners, Inc.
Little Rock Arkansas 72211

A randomized, double blind study of esketamine nasal spray plus an oral antidepressant to prevent return of depression symptoms in patients with treatment-resistant depression (SUSTAIN-1)

Preferred Research Partners
Little Rock Arkansas 72211

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects With Treatment-resistant Depression

APC Clinical Research Trials, PA
Little Rock Arkansas 72211

A study of an investigational Anti-inflammatory medicine as add-on treatment for adults with Major Depressive Disorder

MMG
Little Rock Arkansas 72211

Does Your Child Have Depression?

MMG
Little Rock Arkansas 72211

Does Your Child Have Depression?

MMG
Little Rock Arkansas 72211

Does Your Child Have Depression?

View More ▼

Little Rock Arkansas 72211

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

Little Rock Arkansas 72211

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Little Rock Arkansas

A clinical trial seeking patients for a research study for the treatment of Depressive Disorder, Major

Little Rock Arkansas 72211

A Phase 3 clinical study for patients with Depressive Disorder, Major

Little Rock Arkansas 72211

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

Little Rock Arkansas 72211

Patients are needed to participate in a clinical research study evaluating Intranasal Esketamine for the treatment of Depressive Disorder, Treatment-Resistant

Little Rock Arkansas

Patients are needed to participate in a clinical research study evaluating ITI-007 and Placebo for the treatment of Bipolar Depression

Little Rock Arkansas

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Bipolar Depression

UPDATED

Little Rock Arkansas 72211

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

UPDATED

Little Rock Arkansas 72211

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

Little Rock Arkansas

Patients are needed to participate in a clinical research study of Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day and Placebo to evaluate Depressive Disorder, Major

Rogers Arkansas 72758

A Phase 3 clinical study for patients with Depressive Disorder, Major

Rogers Arkansas

Patients are needed to participate in a clinical research study evaluating ITI-007 and Placebo for the treatment of Bipolar Depression

Rogers Arkansas

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Bipolar Depression

UPDATED

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

UPDATED

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study of TS-121 10 mg, TS-121 50 mg and Placebo to evaluate Major Depressive Disorder

Searcy Arkansas 72143

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Major Depressive Disorder (MDD)

California

MMG
Anaheim California 92804

Does Your Child Have Depression?